{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:31:08Z","timestamp":1792636268598,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.lfs.2023.121988","type":"journal-article","created":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T05:59:59Z","timestamp":1690610399000},"page":"121988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension"],"prefix":"10.1016","volume":"329","author":[{"given":"C\u00e1ssia Lisboa","family":"Braga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Trabach","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Medeiros","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazareth","family":"de Novaes Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathane Santanna","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayck","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique Martins","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnatas Dutra","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas Esteves","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso Caruso","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Rieken Macedo","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Ferreira","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Leme","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.lfs.2023.121988_bb0005","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.202012-4317SO","article-title":"Pulmonary arterial hypertension: diagnosis, treatment, and novel advances","volume":"203","author":"Maron","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"11","key":"10.1016\/j.lfs.2023.121988_bb0010","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.3390\/cells9112338","article-title":"Perivascular inflammation in pulmonary arterial hypertension","volume":"9","author":"Hu","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2023.121988_bb0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-med-041717-085955","article-title":"New and emerging therapies for pulmonary arterial hypertension","volume":"70","author":"Spiekerkoetter","year":"2019","journal-title":"Annu. Rev. Med."},{"issue":"3","key":"10.1016\/j.lfs.2023.121988_bb0020","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.chest.2018.11.030","article-title":"Therapy for pulmonary arterial hypertension in adults: update of the CHEST guideline and expert panel report","volume":"155","author":"Klinger","year":"2019","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.lfs.2023.121988_bb0025","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/ALN.0000000000002740","article-title":"Inflammatory basis of pulmonary arterial hypertension: implications for perioperative and critical care medicine","volume":"131","author":"Goldenberg","year":"2019","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0030","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13287-017-0669-0","article-title":"Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension","volume":"8","author":"de Mendon\u00e7a","year":"2017","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.lfs.2023.121988_bb0035","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jcyt.2019.02.011","article-title":"Adipose-derived mesenchymal stromal cells improve hemodynamic function in pulmonary arterial hypertension: identification of microRNAs implicated in modulating endothelial function","volume":"21","author":"Wang","year":"2019","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13287-019-1224-y","article-title":"Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies","volume":"10","author":"Noronha","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.lfs.2023.121988_bb0045","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1042\/ETLS20210013","article-title":"Mesenchymal stromal cells: what have we learned so far about their therapeutic potential and mechanisms of action?","volume":"5","author":"Amadeo","year":"2021","journal-title":"Emerg. Top. Life Sci."},{"key":"10.1016\/j.lfs.2023.121988_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.661385","article-title":"Mesenchymal stromal cells from emphysematous donors and their extracellular vesicles are unable to reverse cardiorespiratory dysfunction in experimental severe emphysema","volume":"9","author":"Antunes","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2023.121988_bb0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.biochi.2019.10.016","article-title":"Therapeutic efficacy of mesenchymal stromal cells and secretome in pulmonary arterial hypertension: a systematic review and meta-analysis","volume":"168","author":"Muhammad","year":"2020","journal-title":"Biochimie"},{"issue":"12","key":"10.1016\/j.lfs.2023.121988_bb0060","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.4252\/wjsc.v13.i12.1845","article-title":"Strategies to improve regenerative potential of mesenchymal stem cells","volume":"13","author":"Choudhery","year":"2021","journal-title":"World J. Stem Cells"},{"issue":"10","key":"10.1016\/j.lfs.2023.121988_bb0065","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3390\/ijms18102087","article-title":"Challenges and strategies for improving the regenerative effects of mesenchymal stromal cell-based therapies","volume":"18","author":"Baldari","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13287-018-1007-x","article-title":"Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells","volume":"9","author":"Antebi","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"10.1016\/j.lfs.2023.121988_bb0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4252\/wjsc.v14.i7.453","article-title":"Role of hypoxia preconditioning in therapeutic potential of mesenchymal stem-cell-derived extracellular vesicles","volume":"14","author":"Pulido-Escribano","year":"2022","journal-title":"World J. Stem Cells"},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13046-019-1027-0","article-title":"Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery","volume":"38","author":"Ren","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13287-020-01737-0","article-title":"Hypoxia-challenged MSC-derived exosomes deliver miR-210 to attenuate post-infarction cardiac apoptosis","volume":"11","author":"Cheng","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13287-020-02072-0","article-title":"Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice","volume":"12","author":"Dong","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"9\u201310","key":"10.1016\/j.lfs.2023.121988_bb0095","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1089\/neu.2021.0290","article-title":"Exosomes secreted by hypoxia-pre-conditioned adipose-derived mesenchymal stem cells reduce neuronal apoptosis in rats with spinal cord injury","volume":"39","author":"Liang","year":"2022","journal-title":"J. Neurotrauma"},{"issue":"2","key":"10.1016\/j.lfs.2023.121988_bb0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00441-022-03627-8","article-title":"Hypoxia pretreatment enhances the therapeutic potential of mesenchymal stem cells (BMSCs) on ozone-induced lung injury in rats","volume":"389","author":"Abdelrahman","year":"2022","journal-title":"Cell Tissue Res."},{"issue":"12","key":"10.1016\/j.lfs.2023.121988_bb0105","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jcyt.2022.08.009","article-title":"Proteomics profile of mesenchymal stromal cells and extracellular vesicles in normoxic and hypoxic conditions","volume":"24","author":"Braga","year":"2022","journal-title":"Cytotherapy"},{"issue":"7","key":"10.1016\/j.lfs.2023.121988_bb0110","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121988_bb0115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s13770-021-00364-x","article-title":"Strategies to enhance extracellular vesicle production","volume":"18","author":"Hahm","year":"2021","journal-title":"Tissue Eng. Regen. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0120","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13287-022-02849-5","article-title":"Adipose stem cells-released extracellular vesicles as a next-generation cargo delivery vehicles: a survey of minimal information implementation, mass production and functional modification","volume":"13","author":"Chen","year":"2022","journal-title":"Stem Cell Res Ther."},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/stem.1504","article-title":"Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice","volume":"32","author":"Zhu","year":"2014","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0130","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.lfs.2023.121988_bb0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pupt.2015.09.007","article-title":"Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: a network approach","volume":"35","author":"Nogueira-Ferreira","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.lfs.2023.121988_bb0140","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1213\/ANE.0000000000001114","article-title":"The effects of short-term propofol and dexmedetomidine on lung mechanics, histology, and biological markers in experimental obesity","volume":"122","author":"Heil","year":"2016","journal-title":"Anesth. Analg."},{"issue":"2","key":"10.1016\/j.lfs.2023.121988_bb0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCIMAGING.109.887109","article-title":"Noninvasive assessment of murine pulmonary arterial pressure: validation and application to models of pulmonary hypertension","volume":"3","author":"Thibault","year":"2010","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"4","key":"10.1016\/j.lfs.2023.121988_bb0150","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ehjci\/jew041","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of, Cardiovascular Imaging","volume":"17","author":"Foster","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.lfs.2023.121988_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173438","article-title":"Niclosamide attenuates lung vascular remodeling in experimental pulmonary arterial hypertension","volume":"887","author":"Braga","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121988_bb0160","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/10641963.2020.1860077","article-title":"Echocardiographic follow-up to right ventricular modifications in secondary pulmonary hypertension to diabetes in rats","volume":"43","author":"L\u00f3pez Y L\u00f3pez","year":"2021","journal-title":"Clin. Exp. Hypertens."},{"issue":"12","key":"10.1016\/j.lfs.2023.121988_bb0165","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/ars.2020.8169","article-title":"Endothelial-to-mesenchymal transition in pulmonary arterial hypertension","volume":"34","author":"Gorelova","year":"2021","journal-title":"Antioxid. Redox Signal."},{"issue":"23","key":"10.1016\/j.lfs.2023.121988_bb0170","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1111\/bph.14807","article-title":"Effects of the FGF receptor-1 inhibitor, infigratinib, with or without sildenafil, in experimental pulmonary arterial hypertension","volume":"176","author":"Felix","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"20","key":"10.1016\/j.lfs.2023.121988_bb0175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1424774112","article-title":"Interleukin-6\/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension","volume":"112","author":"Hashimoto-Kataoka","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.lfs.2023.121988_bb0180","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/CIRCULATIONAHA.114.008750","article-title":"Endothelial-to-mesenchymal transition in pulmonary hypertension","volume":"131","author":"Ranchoux","year":"2015","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.lfs.2023.121988_bb0185","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1111\/jcmm.17003","article-title":"HIF-1\u03b1 promotes the proliferation and migration of pulmonary arterial smooth muscle cells via activation of Cx43","volume":"25","author":"Han","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.lfs.2023.121988_bb0190","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ejcts.2006.05.026","article-title":"The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension","volume":"30","author":"Gurbanov","year":"2006","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"6","key":"10.1016\/j.lfs.2023.121988_bb0195","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.lfs.2023.121988_bb0200","first-page":"233","article-title":"Pulmonary artery hypertension model in rats by monocrotaline administration","volume":"2018","author":"Bueno-Beti","year":"1816","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.lfs.2023.121988_bb0205","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.chest.2017.10.007","article-title":"Fifty years of monocrotaline-induced pulmonary hypertension: what has it meant to the field?","volume":"152","author":"Hill","year":"2017","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0210","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13287-018-1043-6","article-title":"Impact of one versus two doses of mesenchymal stromal cells on lung and cardiovascular repair in experimental emphysema","volume":"9","author":"Poggio","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.lfs.2023.121988_bb0215","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12015-021-10231-w","article-title":"Clinical trials based on mesenchymal stromal cells are exponentially increasing: where are we in recent years?","volume":"18","author":"Galderisi","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"issue":"12","key":"10.1016\/j.lfs.2023.121988_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12141","article-title":"Mesenchymal stromal cell extracellular vesicles as therapy for acute and chronic respiratory diseases: a meta-analysis","volume":"10","author":"Tieu","year":"2021","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12931-020-1331-4","article-title":"Mesenchymal stromal cell-derived exosomes improve pulmonary hypertension through inhibition of pulmonary vascular remodeling","volume":"21","author":"Zhang","year":"2020","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.lfs.2023.121988_bb0235","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.lfs.2023.121988_bb0240","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.chest.2016.10.061","article-title":"Allogeneic human mesenchymal stem cells in patients with idiopathic pulmonary fibrosis via intravenous delivery (AETHER): a phase I safety clinical trial","volume":"151","author":"Glassberg","year":"2017","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.lfs.2023.121988_bb0245","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/biom10050707","article-title":"Novel applications of mesenchymal stem cell-derived exosomes for myocardial infarction therapeutics","volume":"10","author":"Tan","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.lfs.2023.121988_bb0250","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/ijms22020763","article-title":"Therapeutic properties of mesenchymal stromal\/stem cells: the need of cell priming for cell-free therapies in regenerative medicine","volume":"22","author":"Miceli","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0255","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/ATVBAHA.120.315052","article-title":"Stem\/progenitor cells and pulmonary arterial hypertension","volume":"41","author":"Pu","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121988_bb0260","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.mvr.2009.02.001","article-title":"Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy","volume":"77","author":"Furlani","year":"2009","journal-title":"Microvasc. Res."},{"issue":"4","key":"10.1016\/j.lfs.2023.121988_bb0265","doi-asserted-by":"crossref","DOI":"10.1177\/20458940211046137","article-title":"Effect of dose, dosing intervals, and hypoxic stress on the reversal of pulmonary hypertension by mesenchymal stem cell extracellular vesicles","volume":"11","author":"Klinger","year":"2021","journal-title":"Pulm. Circ."},{"issue":"10","key":"10.1016\/j.lfs.2023.121988_bb0270","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/bies.201200045","article-title":"Amedeo Avogadro's cry: what is 1\u00a0\u03bcg of exosomes?","volume":"34","author":"Sverdlov","year":"2012","journal-title":"BioEssays"},{"issue":"11","key":"10.1016\/j.lfs.2023.121988_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187637","article-title":"Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia\/reperfusion-induced lung injury","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0280","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13287-020-01642-6","article-title":"Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats","volume":"11","author":"Ishiuchi","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.lfs.2023.121988_bb0285","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.3389\/fimmu.2018.02837","article-title":"Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning","volume":"9","author":"Ferreira","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121988_bb0290","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/j.1582-4934.2010.01138.x","article-title":"Survival and function of mesenchymal stem cells (MSCs) depend on glucose to overcome exposure to long-term, severe and continuous hypoxia","volume":"15","author":"Deschepper","year":"2011","journal-title":"J. Cell. Mol. Med."},{"issue":"12","key":"10.1016\/j.lfs.2023.121988_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101351","article-title":"Right heart catheterization (RHC): a comprehensive review of provocation tests and hepatic hemodynamics in patients with pulmonary hypertension (PH)","volume":"47","author":"Gonzalez-Hermosillo","year":"2022","journal-title":"Curr. Probl. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0300","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.113.301129","article-title":"The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure","volume":"115","author":"Ryan","year":"2014","journal-title":"Circ. Res."},{"issue":"14","key":"10.1016\/j.lfs.2023.121988_bb0305","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.3390\/ijms22147447","article-title":"Mesenchymal stem cells therapies on fibrotic heart diseases","volume":"22","author":"Gubert","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2023.121988_bb0310","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fphys.2020.00479","article-title":"Extracellular vesicles as therapeutic agents for cardiac fibrosis","volume":"11","author":"Rogers","year":"2020","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121988_bb0315","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s13287-020-01881-7","article-title":"HIF-1\u03b1 overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis","volume":"11","author":"Sun","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.lfs.2023.121988_bb0320","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00441-016-2539-y","article-title":"Pulmonary vascular remodeling in pulmonary hypertension","volume":"367","author":"Tuder","year":"2017","journal-title":"Cell Tissue Res."},{"issue":"18","key":"10.1016\/j.lfs.2023.121988_bb0325","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/CIRCULATIONAHA.116.022479","article-title":"Endothelial-to-mesenchymal transition: an evolving paradigm and a promising therapeutic target in PAH","volume":"133","author":"Stenmark","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.lfs.2023.121988_bb0330","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1089\/ten.teb.2021.0145","article-title":"Hypoxia-conditioned mesenchymal stem cells in tissue regeneration application","volume":"28","author":"Yang","year":"2022","journal-title":"Tissue Eng. B Rev."},{"key":"10.1016\/j.lfs.2023.121988_bb0335","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.matbio.2014.10.001","article-title":"Multiple-interactions among EMILIN1 and EMILIN2 N- and C-terminal domains","volume":"41","author":"Bot","year":"2015","journal-title":"Matrix Biol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121988_bb0340","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1242\/dmm.015255","article-title":"TGF-\u03b2 mediates early angiogenesis and latent fibrosis in an Emilin1-deficient mouse model of aortic valve disease","volume":"7","author":"Munjal","year":"2014","journal-title":"Dis. Model. Mech."},{"issue":"9","key":"10.1016\/j.lfs.2023.121988_bb0345","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1161\/ATVBAHA.112.254664","article-title":"Vascular smooth muscle Emilin-1 is a regulator of arteriolar myogenic response and blood pressure","volume":"32","author":"Litteri","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2023.121988_bb0350","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.matbio.2022.06.005","article-title":"EMILIN-1 deficiency promotes chronic inflammatory disease through TGF\u03b2 signaling alteration and impairment of the gC1q\/\u03b14\u03b21 integrin interaction","volume":"111","author":"Pivetta","year":"2022","journal-title":"Matrix Biol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121988_bb0355","first-page":"1659","article-title":"Myocardial reparative functions of exosomes from mesenchymal stem cells are enhanced by hypoxia treatment of the cells via transferring microRNA-210 in an nSMase2-dependent way","volume":"46","author":"Zhu","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121988_bb0360","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41419-021-03713-9","article-title":"Hypoxia-induced miR-210 modulates the inflammatory response and fibrosis upon acute ischemia","volume":"12","author":"Zaccagnini","year":"2021","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.lfs.2023.121988_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088685","article-title":"Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22","volume":"9","author":"Feng","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lfs.2023.121988_bb0370","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3349\/ymj.2018.59.6.736","article-title":"Extracellular vesicles derived from hypoxic human mesenchymal stem cells attenuate GSK3\u03b2 expression via miRNA-26a in an ischemia-reperfusion injury model","volume":"59","author":"Park","year":"2018","journal-title":"Yonsei Med. J."},{"issue":"4","key":"10.1016\/j.lfs.2023.121988_bb0375","first-page":"223","article-title":"STAT3 signaling in pulmonary arterial hypertension","volume":"1","author":"Paulin","year":"2012","journal-title":"JAKSTAT"},{"issue":"21","key":"10.1016\/j.lfs.2023.121988_bb0380","doi-asserted-by":"crossref","first-page":"14665","DOI":"10.1074\/jbc.M707429200","article-title":"Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function","volume":"283","author":"Cheng","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.lfs.2023.121988_bb0385","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3892\/or.2015.3783","article-title":"STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells","volume":"33","author":"Zhang","year":"2015","journal-title":"Oncol. Rep."},{"issue":"9","key":"10.1016\/j.lfs.2023.121988_bb0390","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.3390\/ijms22094980","article-title":"The role of JAK\/STAT molecular pathway in vascular remodeling associated with pulmonary hypertension","volume":"22","author":"Roger","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2023.121988_bb0395","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/biores.2012.9905","article-title":"HIF-1\u03b1 overexpression induces angiogenesis in mesenchymal stem cells","volume":"1","author":"Razban","year":"2012","journal-title":"BioRes. Open Access"},{"issue":"6","key":"10.1016\/j.lfs.2023.121988_bb0400","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.yjmcc.2007.04.001","article-title":"HIF-1alpha induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia","volume":"42","author":"Dai","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121988_bb0405","first-page":"L700","article-title":"Neovascularization in the pulmonary endothelium is regulated by the endosome: Rab4-mediated trafficking and p18-dependent signaling","volume":"309","author":"Chichger","year":"2015","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"12 Suppl S","key":"10.1016\/j.lfs.2023.121988_bb0410","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121988_bb0415","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1148\/radiol.2020203108","article-title":"Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society","volume":"298","author":"Remy-Jardin","year":"2021","journal-title":"Radiology"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523006239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523006239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T19:42:41Z","timestamp":1736365361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523006239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":83,"alternative-id":["S0024320523006239"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121988","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"121988"}}